Sponsors and Exhibitors

Dr. Sennewald Medizintechnik has over 30 years of experience in medical technology. For regional and local hyperthermia in clinical oncology, we entered into a partnership with the pioneer and market leader Pyrexar Medical. Our connections to the scientific community have led to the acceptance of hyperthermia, development of certified software and reimbursement of hyperthermia. Our enthusiasm for innovative radiotherapy systems has led us to become the exclusive distributor of FLASH radiotherapy systems by SIT for the German market.

www.sennewald.de

Since 1995 heckel medizintechnik GmbH Esslingen/Germany has established itself as a pioneer in hyperthermia. In a strategic partnership with medical device manufacturer and specialist in water-filtered infrared A technique, Hydrosun Medizintechnik GmbH Müllheim, heckel offers:

Whole-Body Hyperthermia (WBH) system heckel-HT3000 for the systemic elevation of core body temperature to mild (approx. 38.5°C), fever-range (38.5-40.5°C) or extreme levels (up to 42°C). Our focus is on fever-range WBH to stimulate anti-tumour immune effects and induce chances in tumour perfusion as adjunctive therapy in cancer treatments. In addition to its use in oncology, heckel WBH systems are used in the treatment of chronic inflammation, chronic infection and musculoskeletal pain. A strong anti-depressive effect has been confirmed in a RCT.

The Thermography-controlled, Water-filtered infrared A superficial Hyperthermia device hydrosun-TWH1500 is a world-first device for contact-free superficial hyperthermia. It has the ability to treat large areas independent of heterogeneous body contours. Continuous real-time thermographic control with automatic off/on switch allows for an optimal and safe energy input. The patient does not suffer from any physical restriction or painful applicator contact, as may be experienced for example with ulcerated lesions. The risk of acute thermal skin damage has been reduced to almost 0% even in difficult areas (e.g., tissue transfer).

www.heckel-hyperthermia.com

Med-Logix designs, manufactures, and sells innovative hyperthermia systems for oncology, physiotherapy, and sports medicine.

Med-Logix began its activities in 2009 with the sale of the ALBA ON 4000 devices for superficial hyperthermia. From 2010 onwards Med-Logix has started a series of technical and scientific collaborations with several excellent university centers, such as the University of Tor Vergata (Rome, Italy), the AMC/University of Amsterdam (Amsterdam, Netherlands), ErasmusMC (Rotterdam, Netherlands), the Czech Technical University (Prague, Czech Republic), for the development of innovative and technically advanced customized projects in the field of oncological hyperthermia. From the collaborations with these academic institutions, Med-Logix Srl has managed to develop and market the most advanced hyperthermia products for the radiation oncology field. The ALBA devices are now installed in radiotherapy departments of top cancer hospitals and research centers in Europe, the Middle East, and Asia. From 2012 to 2018 Med-Logix has developed ALBA 4D, the most advanced phased array system for oncological deep hyperthermia in the world, which is now CE marked and installed in prestigious cancer centers in Europe and in S.E Asia.

www.albahyperthermia.com

Sensius improves the perspective for cancer patients by using thermotherapy. Increasing the temperature of the tumour results in better clinical outcome and lower toxicity, leading to an increased Quality of Life and lower costs.  Sensius sets the ambition to be the best in thermotherapy through research and continuous collaboration with clinical teams worldwide.

Sensius delivers controlled heating of deep-seated tumours, while at the same time preserving the surrounding tissues and organs. Our patented technology provides high performance in focus and control of the heat, easy adoption through alignment with the radiotherapy workflow and economic benefits for clinics.

www.sensiusthermotherapy.com